Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma

Zong Y, Peng Z, Wang X, Lu M, Shen L, Zhou J

Cancer Management and Research 2020, 12:12657-12666

Published Date: 9 December 2020